BiomX to Acquire DFSL with $12 Warrants, Adds 99%-Accurate LADAR
BiomX will acquire controlling interest in Israeli defense firm DFSL for cash, an unsecured convertible note, $12 warrants and a revenue-linked bonus, expanding its defense portfolio. DFSL’s LADAR detection system achieves roughly 99% accuracy and connects with BiomX’s Zorronet AI platform for real-time threat tracking and response.
1. Acquisition Details
BiomX entered a definitive agreement to acquire a controlling interest in Israeli defense engineering firm DFSL, expanding its portfolio into high-precision detection systems. The transaction consideration includes a cash payment, an unsecured convertible note, warrants exercisable at $12 per share and a revenue-linked bonus, subject to regulatory and shareholder approvals.
2. Strategic Expansion
This deal complements BiomX’s recent acquisition of the Zorronet AI command-and-control platform by adding DFSL’s LADAR technology, enabling an integrated solution that spans real-time detection, analysis and response for defense, critical infrastructure and first-response applications.
3. DFSL Technology
DFSL’s proprietary LADAR platform combines laser-based sensing with on-board AI algorithms to deliver approximately 99% real-world threat detection accuracy, significantly reducing false positives and providing a reliable last line of defense in perimeter security and counter-UAS operations.
4. Deal Terms and Timing
The transaction is contingent on approvals from Israeli regulators and NYSE American shareholders. Its structure aligns incentives through convertible securities and performance-based bonus payments tied to defined revenue milestones, reinforcing long-term value creation.